Mylan stock boost follows long share struggles for company, generics industry By Reuters
© Reuters. Mylan stock boost follows long share struggles for company, generics industry By Lewis Krauskopf NEW YORK (Reuters) – Shares of Mylan NV (O:) surged on Monday after the generic drugmaker agreed to combine with Pfizer Inc’s (N:) off-patent branded drugs business. But in the bigger picture, the surgeRead More →